References
Brophy VH, Jarvik GP, Richter RJ, Rozek LS, Schellenberg GD, Furlong CE (2000) Analysis of paraoxonase (PON1) L55 M status requires both genotype and phenotype. Pharmacogenetics 10:453–460
Bryk B, BenMoyal-Segal L, Podoly E, Livnah O, Eisenkraft A, Luria S, Cohen A, Yehezkelli Y, Hourvitz A, Soreq H (2005) Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities. J Neurochem 92:1216–1227
Campo S, Sardo MA, Trimarchi G, Bonaiuto M, Fontana L, Castaldo M, Bonaiuto A, Saitta C, Bitto A, Manduca B, Riggio S, Saitta A (2004) Association between serum paraoxonase (PON1) gene promoter T(−107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians. Exp Gerontol 39:1089–1094
Jarvik GP, Rozek LS, Brophy VH, Hatsukami TS, Richter RJ, Schellenberg GD, Furlong CE (2000) Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1(192) or PON1(55) genotype. Arterioscler Thromb Vasc Biol 20:2441–2447
Jarvik GP, Hatsukami TS, Carlson C, Richter RJ, Jampsa R, Brophy VH, Margolin S, Rieder M, Nickerson D, Schellenberg GD, Heagerty PJ, Furlong CE (2003) Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease. Arterioscler Thromb Vasc Biol 23:1465–1471
Leviev I, Deakin S, James RW (2001) Decreased stability of the M54 isoform of paraoxonase as a contributory factor to variations in human serum paraoxonase concentrations. J Lipid Res 42:528–535
Mackness MI, Arrol S, Durrington PN (1991) Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 286:152–154
Nishio E, Watanabe Y (1997) Cigarette extract inhibits plasma paraoxonase activity by modification of the enzyme’s free thiols. Biochem Biophys Commun 236:289–293
Phuntuwate W, Suthisisang C, Koanantakul B, Mackness MI, Mackness B (2005) Paraoxonase 1 status in the Thai population. J Hum Genet 50:293–300
Rao MN, Marmillot P, Gong M, Palmer DA, Seeff LB, Strader DB, Lakshman MR (2003) Light, but not heavy alcohol drinking, stimulates paraoxonase by upregulating liver mRNA in rats and humans. Metabolism 52:1287–1294
Saha N, Roy AC, Teo SH, Tay JS, Ratnam SS (1991) Influence of serum paraoxonase polymorphism on serum lipids and apolipoproteins. Clin Genet 40:277–282
Seres I, Paragh G, Deschene E, Fulop T Jr, Khalil A (2004) Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp Gerontol 39:59–66
Acknowledgments
This study was supported by a grant from the Post-Graduate Education, Training, and Research Program in Environmental Science, Technology, and Management under the Higher Education Development Project of the Commission on Higher Education, Ministry of Education, Thailand.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sirivarasai, J., Kaojarern, S., Sura, T. et al. Biochemical, Environmental, and Genetic Factors Associated with Paraoxonase (PON1) Activity. Biochem Genet 49, 364–368 (2011). https://doi.org/10.1007/s10528-010-9413-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-010-9413-5